Patricia A. Turney - 23 Mar 2022 Form 4/A - Amendment Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
SVP, Operations
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Patricia A. Turney
Issuer symbol
ARQT
Transactions as of
23 Mar 2022
Net transactions value
+$99,958
Form type
4/A - Amendment
Filing time
04 Aug 2022, 20:42:29 UTC
Date Of Original Report
23 Mar 2022
Previous filing
07 Mar 2022
Next filing
02 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Options Exercise $99,958 +15,331 +49% $6.52 46,444 23 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Options Exercise $0 -15,331 -9.6% $0.000000 144,612 23 Mar 2022 Common Stock 15,331 $6.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 24,925 restricted stock units.
F2 The option vests as to 1/4 of the total shares on November 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on November 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Remarks:

Amendment filed to correct administrative error, the exercise amount should have been 15,331 and not 25,328 options exercised.